<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="146284">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01886586</url>
  </required_header>
  <id_info>
    <org_study_id>10110050</org_study_id>
    <nct_id>NCT01886586</nct_id>
  </id_info>
  <brief_title>Retaining Cognition While Avoiding Late-Life Depression</brief_title>
  <acronym>RECALL</acronym>
  <official_title>RECALL: Retaining Cognition While Avoiding Late-Life Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <authority>United States: Federal Government</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will adapt Problem Solving Therapy (PST) for individuals with mild cognitive
      impairment (MCI) as an intervention for preventing major depression (DEP). PST will be
      modified so as to be provided to both MCI probands as well as their support person. The
      primary aim is to examine the effectiveness of PST in individuals with MCI and the support
      person, at preventing DEP over 12 mos. in MCI probands. We also will examine the effect of
      exercise on preventing depression.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Recall Study (Retaining Cognition while Avoiding Late-Life Depression) is a study for
      adults 60 and older who have noticed mild memory changes in themselves or a loved one. Mild
      memory changes may feel stressful and therefore increase an individual's risk of developing
      depression. This research project will test whether Problem Solving Therapy (PST) is
      successful in preventing major depression for those living with mild cognitive impairments.
      We will also examine the effect of modest exercise on mood. You will participate in 8 to 12
      PST sessions over 16 weeks. All treatments are provided at no cost and there is compensation
      for participation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Incidence of depression or anxiety disorders</measure>
    <time_frame>15 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>PHQ9, prime-MD SCID, GAD7</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in cognitive function measured by RBANS and DKEFS</measure>
    <time_frame>15 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>RBANS, DKEFS, 3MS, PASS, CAMCI, CIRS-G, RAND-12, LLFDI, SPPB, PSQI, NRS, ISEL,  PROMIS, Acornell Services Index, P-GIC, ZARIT, DAS</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">136</enrollment>
  <condition>Mild Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>Probelm Solving Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>8-12 sessions of Problem Solving Therapy (both members of dyad)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Problem Solving Therapy + Exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>6-12 sessions of Problem Solving Therapy + Exercise (both members of dyad)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Enhanced Usual Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Staff will will document and monitor all mental health treatment (e.g., medications that participant may be taking) and psychotherapy (e.g. counseling or social services).</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Problem Solving Therapy</intervention_name>
    <description>6-12 sessions of Problem Solving Therapy (both members of dyad)</description>
    <arm_group_label>Probelm Solving Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Problem Solving Therapy + Exercise</intervention_name>
    <description>6-12 sessions of Problem Solving Therapy + Exercise (both members of dyad)</description>
    <arm_group_label>Problem Solving Therapy + Exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Enhanced Usual Care</intervention_name>
    <description>Staff will document and monitor all mental health treatment (e.g., medications that participant may be taking) and psychotherapy (e.g. counseling or social services).</description>
    <arm_group_label>Enhanced Usual Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        MCI participant Inclusion Criteria:

          1. =&gt; age 60

          2. Modified Mini Mental State (3MS) =&gt; 80

          3. MCI diagnosis

          4. Adequate physical and sensory function to undergo NP assessment

          5. PHQ-9 score 1-9, with at least one of the cardinal symptoms of depression (low mood
             or anhedonia) endorsed.

        MCI participant Exclusion Criteria:

          1. Major Depressive Episode or anxiety disorder within the past 1 year

          2. Currently taking an anti-depressant

          3. History of Bipolar Disorder or Schizophrenia

          4. Drug or alcohol use disorder within 12 months

          5. Currently taking anti-anxiety med &gt;4x/week for the past 4 weeks

        Support person Inclusion Criteria:

          1. =&gt; age 18

          2. Modified Mini Mental State (3MS) =&gt; 80

          3. Normal Cognitive Function

          4. Adequate physical and sensory function to undergo NP assessment

          5. PHQ-9 score 1-9, with at least one of the cardinal symptoms of depression (low mood
             or anhedonia) endorsed.

        Support person Exclusion Criteria:

          1. Major Depressive Episode or anxiety disorder within the past 1 year

          2. Currently taking an anti-depressant

          3. History of Bipolar Disorder or Schizophrenia

          4. Drug or alcohol use disorder within 12 months

          5. Currently taking anti-anxiety med &gt;4x/week for the past 4 weeks
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Meryl Butters, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ariel Gildengers, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michelle Zmuda, BS</last_name>
    <phone>412-246-4687</phone>
    <email>zmudamd@upmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shannon Evan, MS</last_name>
    <phone>412-246-6487</phone>
    <email>evansl@upmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UPMC Western Psychiatric Institute and Clinic</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meryl Butters, MS</last_name>
      <phone>412-246-5280</phone>
      <email>buttersma@upmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Michelle Zmuda, BS</last_name>
      <phone>412-246-6487</phone>
      <email>zmudamd@upmc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Meryl Butters, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ariel Gildengers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UPMC Late-Life Evaluation and Treatment Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacqueline Stack, MSN, APRN</last_name>
      <phone>412-246-6006</phone>
      <email>stackja@upmc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.imanagestress.org/</url>
    <description>iManage studies website</description>
  </link>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 7, 2014</lastchanged_date>
  <firstreceived_date>June 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mild Cognitive Impairment</keyword>
  <keyword>memory impairment</keyword>
  <keyword>problem-solving therapy</keyword>
  <keyword>depression prevention</keyword>
  <keyword>caregiver stress</keyword>
  <keyword>exercise</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Cognition Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
